Dianthus Therapeutics (DNTH) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to -$0.97.
- Dianthus Therapeutics' EPS (Weighted Average and Diluted) fell 3108.11% to -$0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.49, marking a year-over-year decrease of 14874.3%. This contributed to the annual value of -$2.54 for FY2024, which is 6998.28% up from last year.
- Per Dianthus Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.97 for Q3 2025, which was down 3108.11% from -$0.88 recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' EPS (Weighted Average and Diluted) peaked at $8.95 during Q4 2023, and registered a low of -$12.73 during Q2 2023.
- Its 4-year average for EPS (Weighted Average and Diluted) is -$3.19, with a median of -$0.88 in 2025.
- Per our database at Business Quant, Dianthus Therapeutics' EPS (Weighted Average and Diluted) surged by 17735.52% in 2023 and then plummeted by 10936.61% in 2024.
- Quarter analysis of 4 years shows Dianthus Therapeutics' EPS (Weighted Average and Diluted) stood at -$11.57 in 2022, then skyrocketed by 177.36% to $8.95 in 2023, then crashed by 109.37% to -$0.84 in 2024, then dropped by 15.71% to -$0.97 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.97 in Q3 2025, compared to -$0.88 in Q2 2025 and -$0.82 in Q1 2025.